MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹682 Cr | ₹436 Cr | ₹354 Cr | ₹280 Cr | ₹245 Cr |
What is the latest Short Term Provisions ratio of MANKIND PHARMA ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹682 Cr |
| Mar2024 | ₹436 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹280 Cr |
| Mar2021 | ₹245 Cr |
How is Short Term Provisions of MANKIND PHARMA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹682 Cr | 56.52 | |
| Mar2024 | ₹436 Cr | 23.12 | |
| Mar2023 | ₹354 Cr | 26.57 | |
| Mar2022 | ₹280 Cr | 13.98 | |
| Mar2021 | ₹245 Cr | - | |
Compare Short Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹97,333.8 Cr | -0.6% | -5.9% | 0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.6% |
-5.9% |
0.1% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses